JPWO2023033178A5 - - Google Patents

Info

Publication number
JPWO2023033178A5
JPWO2023033178A5 JP2023545715A JP2023545715A JPWO2023033178A5 JP WO2023033178 A5 JPWO2023033178 A5 JP WO2023033178A5 JP 2023545715 A JP2023545715 A JP 2023545715A JP 2023545715 A JP2023545715 A JP 2023545715A JP WO2023033178 A5 JPWO2023033178 A5 JP WO2023033178A5
Authority
JP
Japan
Prior art keywords
cancer
subject
amount
biological sample
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023545715A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023033178A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/033332 external-priority patent/WO2023033178A1/ja
Publication of JPWO2023033178A1 publication Critical patent/JPWO2023033178A1/ja
Publication of JPWO2023033178A5 publication Critical patent/JPWO2023033178A5/ja
Pending legal-status Critical Current

Links

JP2023545715A 2021-09-03 2022-09-05 Pending JPWO2023033178A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021144350 2021-09-03
PCT/JP2022/033332 WO2023033178A1 (ja) 2021-09-03 2022-09-05 癌についての情報を提供する方法、癌についての情報を提供するシステム及び癌を治療する方法

Publications (2)

Publication Number Publication Date
JPWO2023033178A1 JPWO2023033178A1 (https=) 2023-03-09
JPWO2023033178A5 true JPWO2023033178A5 (https=) 2025-09-12

Family

ID=85412495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023545715A Pending JPWO2023033178A1 (https=) 2021-09-03 2022-09-05

Country Status (3)

Country Link
US (1) US20250003971A1 (https=)
JP (1) JPWO2023033178A1 (https=)
WO (1) WO2023033178A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026023560A (ja) * 2024-07-31 2026-02-13 Kagami株式会社 神経膠腫に関する情報を提供する方法及びシステム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013140785A1 (ja) * 2012-03-18 2013-09-26 国立大学法人九州大学 疾患サンプル分析装置、分析システム及び分析方法
WO2020080482A1 (ja) * 2018-10-17 2020-04-23 株式会社 資生堂 血液中のシスタチンｃ量に基づく腎機能検査結果の妥当性を検定する方法
JPWO2020080491A1 (ja) * 2018-10-17 2021-09-09 Kagami株式会社 血液中のクレアチニン量に基づく腎機能検査結果の妥当性を検定する方法
WO2020196436A1 (ja) * 2019-03-22 2020-10-01 Kagami株式会社 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム
JP6993654B2 (ja) * 2019-12-27 2022-02-15 Kagami株式会社 腎機能を推定する方法及びシステム

Similar Documents

Publication Publication Date Title
Gudelj et al. Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up
CN106537130B (zh) 用于分析物检测的电化学传感器
US12448654B2 (en) Compositions and methods for detecting pancreatic cancer
US20220003774A1 (en) Kidney disease prognosis prediction method and system
US11971410B2 (en) Methods of classifying response to immunotherapy for cancer
TR201904386T4 (tr) Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem.
KR20150036388A (ko) 위장관, 특히 장에서의 병리학적 변화를 검출하기 위하여 대변에서 바이오마커의 동기적 증명을 위한 시험 키트 (복합-신속 시험)
JP2021518432A5 (https=)
CN113493829B (zh) 生物标志物在肺动脉高压诊疗中的应用
Ihara et al. A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders
JP2024512490A (ja) 患者を分類かつ治療する方法
JPWO2023033178A5 (https=)
CA3249862A1 (en) MULTI-LEVEL SCREENING AND ANALYSIS
AU2014236152B2 (en) Methods and compositions for diagnosing preeclampsia
Brock et al. A multiplex serum protein assay for determining the probability of colorectal cancer
Gupta et al. Urinary CXC-motif ligand 9 (CXCL9) in immune checkpoint inhibitor–associated acute interstitial nephritis
Paziewska-Nowak et al. DNA-based molecular recognition system for lactoferrin biosensing
CN101523218B (zh) 评估类风湿性关节炎患者疾病进展的风险
Awwad et al. Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation
AU2020343654A1 (en) Noninvasive method to quantify kidney function and functional decline
WO2023033178A1 (ja) 癌についての情報を提供する方法、癌についての情報を提供するシステム及び癌を治療する方法
TWI735470B (zh) 糖尿病性腎病之判定方法、及於此種判定方法中生物標記之用途
US20240304331A1 (en) Method for providing information related to type of cancer, system for providing information related to type of cancer
CN113789387B (zh) 标志物在诊断腹主动脉瘤中的用途
Słodkowska et al. Digital pathology in personalized cancer therapy